TAAV Biomanufacturing Solutions is a CDMO specializing in enzymatic DNA production (neDNA) as a critical starting material for AAV (adeno-associated virus) gene therapy manufacturing. Their core product is neDNA -- a synthetic, linear, double-stranded, closed-ended DNA molecule designed as an alternative to plasmids for transfection-based AAV production. The company works with biopharma companies, research centers, and entities developing AAV-based gene therapies. TAAV is part of the Viralgen/AskBio (Bayer) ecosystem, based in Spain with UK registration.
Enzymatic DNA production, neDNA technology, AAV gene therapy starting materials, plasmid alternatives for gene therapy
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.